Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weiming Li

Showing results (441-450 of 465) with videos related to

Pageof 47
Sort By:
Haematologica|June 27, 2024
Safety and efficacy of flumatinib as later-line therapy in patients with chronic myeloid leukemiaYunfan Yang, Yuntao Liu, Hui Sun, et al.
Biochemical and Biophysical Research Communications|December 27, 2005
Extremely low penetrance of deafness associated with the mitochondrial 12S rRNA mutation in 16 Chinese families: implication for early detection and prevention of deafnessPu Dai, Xin Liu, Dongyi Han, et al.
British Journal of Pharmacology|September 13, 2017
Repurposing a novel parathyroid hormone analogue to treat hypoparathyroidismVenkatesh Krishnan, Yanfei L Ma, Catherine Z Chen, et al.
Horticulture Research|September 20, 2023
Chromosome-scale genome sequence of <i>Suaeda glauca</i> sheds light on salt stress tolerance in halophytesYan Cheng, Jin Sun, Mengwei Jiang, et al.
Cancer Medicine|July 6, 2023
Quality-of-life, mental health, and perspective on TKI dose reduction as a prelude to discontinuation in chronic phase chronic myeloid leukemiaYilin Chen, Na Xu, Yunfan Yang, et al.
Annals of Hematology|January 22, 2025
Adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation and tyrosine kinase inhibitors: development and validation of a clinical prediction model based on cytogenetics, IKZF1 deletions and minimal residual diseaseJing Zheng, Yuping Zhou, Yanmin Zhao, et al.
Cell Reports|January 24, 2026
A shear stress-responsive pathway in monocytes drives cardiopulmonary bypass-induced inflammation via spectrin/RAF1/store-operated calcium entryWeiming Li, Lan N Tu, Lance Hsieh, et al.
The Science of the Total Environment|December 23, 2021
Greenness alleviates the effects of ambient particulate matter on the risks of high blood pressure in children and adolescentsLi Chen, Junqing Xie, Tao Ma, et al.
Hepatology (Baltimore, Md.)|March 15, 2018
Tyrosine kinase SYK is a potential therapeutic target for liver fibrosisChen Qu, Dandan Zheng, Sai Li, et al.
Journal of Hematology & Oncology|August 18, 2022
Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trialQian Jiang, Zongru Li, Yazhen Qin, et al.
Pageof 47

Showing results (441-450 of 465) with videos related to

Sort By:
Pageof 47
Haematologica|June 27, 2024
Safety and efficacy of flumatinib as later-line therapy in patients with chronic myeloid leukemiaYunfan Yang, Yuntao Liu, Hui Sun, et al.
Biochemical and Biophysical Research Communications|December 27, 2005
Extremely low penetrance of deafness associated with the mitochondrial 12S rRNA mutation in 16 Chinese families: implication for early detection and prevention of deafnessPu Dai, Xin Liu, Dongyi Han, et al.
British Journal of Pharmacology|September 13, 2017
Repurposing a novel parathyroid hormone analogue to treat hypoparathyroidismVenkatesh Krishnan, Yanfei L Ma, Catherine Z Chen, et al.
Horticulture Research|September 20, 2023
Chromosome-scale genome sequence of <i>Suaeda glauca</i> sheds light on salt stress tolerance in halophytesYan Cheng, Jin Sun, Mengwei Jiang, et al.
Cancer Medicine|July 6, 2023
Quality-of-life, mental health, and perspective on TKI dose reduction as a prelude to discontinuation in chronic phase chronic myeloid leukemiaYilin Chen, Na Xu, Yunfan Yang, et al.
Annals of Hematology|January 22, 2025
Adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation and tyrosine kinase inhibitors: development and validation of a clinical prediction model based on cytogenetics, IKZF1 deletions and minimal residual diseaseJing Zheng, Yuping Zhou, Yanmin Zhao, et al.
Cell Reports|January 24, 2026
A shear stress-responsive pathway in monocytes drives cardiopulmonary bypass-induced inflammation via spectrin/RAF1/store-operated calcium entryWeiming Li, Lan N Tu, Lance Hsieh, et al.
The Science of the Total Environment|December 23, 2021
Greenness alleviates the effects of ambient particulate matter on the risks of high blood pressure in children and adolescentsLi Chen, Junqing Xie, Tao Ma, et al.
Hepatology (Baltimore, Md.)|March 15, 2018
Tyrosine kinase SYK is a potential therapeutic target for liver fibrosisChen Qu, Dandan Zheng, Sai Li, et al.
Journal of Hematology & Oncology|August 18, 2022
Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trialQian Jiang, Zongru Li, Yazhen Qin, et al.
Pageof 47